Cubar, Evangeline A.

HRN: 27 44 21  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/26/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/26/2026
03/04/2026
IV
2.25gm
Q8
Septicemia
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: